# Melatonin and Radiation Therapy in Treating Patients With Brain Metastases

> **NCT00031967** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group**

## Conditions studied

- Metastatic Cancer
- Radiation Toxicity
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** therapeutic melatonin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00031967
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2004-03
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031967, "Melatonin and Radiation Therapy in Treating Patients With Brain Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00031967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*